Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 19:27
Savara Price : 5.565 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 5.54 | 5.64 | 5.50 | 5.59 | 3.035M |
| Aug 20, 2026 | 5.52 | 5.59 | 5.26 | 5.49 | 2.542M |
| Aug 19, 2026 | 5.49 | 5.60 | 5.395 | 5.58 | 1.298M |
| Aug 18, 2026 | 5.33 | 5.43 | 5.285 | 5.37 | 1.510M |
| Aug 17, 2026 | 5.39 | 5.43 | 5.285 | 5.37 | 1.207M |
| Aug 14, 2026 | 5.25 | 5.40 | 5.14 | 5.38 | 1.650M |
| Aug 13, 2026 | 5.75 | 5.79 | 5.25 | 5.27 | 1.874M |
| Aug 12, 2026 | 5.91 | 5.92 | 5.575 | 5.70 | 1.175M |
| Aug 11, 2026 | 5.81 | 5.98 | 5.53 | 5.57 | 1.264M |
| Aug 10, 2026 | 5.82 | 5.93 | 5.63 | 5.73 | 1.207M |
| Aug 07, 2026 | 5.87 | 5.99 | 5.785 | 5.83 | 1.586M |
| Aug 06, 2026 | 5.52 | 5.81 | 5.52 | 5.79 | 1.008M |
| Aug 05, 2026 | 5.43 | 5.53 | 5.36 | 5.51 | 1.603M |
| Aug 04, 2026 | 5.45 | 5.525 | 5.375 | 5.41 | 1.362M |
| Aug 03, 2026 | 5.44 | 5.49 | 5.31 | 5.33 | 1.640M |
| Jul 31, 2026 | 5.54 | 5.63 | 5.35 | 5.46 | 1.169M |
| Jul 30, 2026 | 5.31 | 5.55 | 5.255 | 5.54 | 1.243M |
| Jul 29, 2026 | 5.34 | 5.40 | 5.18 | 5.28 | 1.259M |
| Jul 28, 2026 | 5.545 | 5.565 | 5.245 | 5.33 | 1.679M |
| Jul 27, 2026 | 5.56 | 5.68 | 5.43 | 5.43 | 3.792M |
| Jul 24, 2026 | 5.79 | 5.855 | 5.475 | 5.51 | 1.550M |
| Jul 23, 2026 | 5.51 | 5.815 | 5.45 | 5.75 | 1.622M |
| Jul 22, 2026 | 5.80 | 5.87 | 5.645 | 5.65 | 3.406M |
| Jul 21, 2026 | 5.51 | 6.025 | 5.47 | 5.84 | 2.863M |
| Jul 20, 2026 | 5.54 | 5.659 | 5.405 | 5.49 | 1.365M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 146.76 |
| Insmed, Inc. | 124.03 |
| United Therapeutics Corp. | 513.04 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
| SELLAS Life Sciences Group, Inc. | 14.32 |
Price Related Metrics
| PEG Ratio | -0.7785 |
| Price to Book Value | 7.957 |
| Earnings Yield | -10.36% |
| Market Cap | 1.143B |
| PEGY Ratio | -0.7785 |